Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bio Immunitas Enters Manufacturing Collaboration with GenScript ProBio | Contract Pharma
Breaking News, Collaborations & Alliances

Bio Immunitas Enters Manufacturing Collaboration with GenScript ProBio

The partnership will fast-track Bio Immunitas' manufacturing and production from bench to bedside in an expedited timescale while maintaining regulatory milestones.

GenScript ProBio, a biologics contract development and manufacturing organization (CDMO) to the biopharmaceutical market, and Bio Immunitas, a UK pharmaceutical company with a novel, safe and efficacious human Recombinant Protein Platform (hRPP), announced a partnership for developing potential novel therapies for clinical use. 

The long-term partnership will fast-track Bio Immunitas’ manufacturing and production from bench to bedside in an expedited timescale while maintaining regulatory milestones.

GenScript ProBio provides IND-enabling CMC services for Bio Immunitas to accelerate the preclinical development of 2 recombinant protein products using Bio Immunitas’ proprietary hRPP platform.

“This relationship will help us realize our commitment to creating innovative, differentiated treatments for millions of patients,” said Syed Haq, CEO/CMO of Bio Immunitas.

Brian Min, the CEO of GenScript ProBio, said, “We’re delighted to collaborate with Bio Immunitas to accelerate its novel therapeutic platform and expect more patients will benefit from this superior treatment.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters